Short interruptions – such as the few seconds it takes to silence that buzzing smartphone – have a surprisingly large effect on one's ability to accurately complete a task, according to new research led by Michigan State University.
The study, in which 300 people performed a sequence-based procedure on a computer, found that interruptions of about three seconds doubled the error rate.
Brief interruptions are ubiquitous in today's society, from text messages to a work colleague poking his head in the door and interrupting an important conversation. But the ensuing errors can be disastrous for professionals such as airplane mechanics and emergency room doctors, said Erik Altmann, lead researcher on the study.
"What this means is that our health and safety is, on some level, contingent on whether the people looking after it have been interrupted," said Altmann, MSU associate professor of psychology.
The study, funded by the U.S. Navy's Office of Naval Research, is one of the first to examine the effects of brief interruptions on relatively difficult tasks. The findings appear in the Journal of Experimental Psychology: General.
Study participants were asked to perform a series of tasks in order, such as identifying with a keystroke whether a letter was closer to the start or the end of the alphabet. Even without interruptions a small number of errors in sequence were made.
Sometimes participants were interrupted and told to type two letters – which took 2.8 seconds – before returning to the task. When this happened, they were twice as likely to mess up the sequence.
Altmann said he was surprised that such short interruptions had a large effect. The interruptions lasted no longer than each step of the main task, he noted, so the time factor likely wasn't the cause of the errors.
"So why did the error rate go up?" Altmann said. "The answer is that the participants had to shift their attention from one task to another. Even momentary interruptions can seem jarring when they occur during a process that takes considerable thought."
One potential solution, particularly when errors would be costly, is to design an environment that protects against interruptions. "So before you enter this critical phase: All cell phones off at the very least," Altmann said.
Michigan State University: http://www.newsroom.msu.edu
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Dr Jeremy Farrar of Wellcome Trust says international community is belatedly taking actions necessary to stem tide of disease
Miniature stomachs gastric organoids will help in study of ulcers and could be used in future to repair patients stomachs
The story of the vaccines development is just one part of a rich and intertwined history of scientific discovery and controversy
A highly sensitive blood test for Ebola exists, so why isn't it being used to test all returning health workers from West Africa? Because the virus isn't in the blood in the first stages of infection.
Drinking beverages enriched with compounds found in cocoa beans improved older adults' performances on a memory test – but there's a catch
A 700-year-old caribou dropping from northern Canada holds surprisingly well-preserved viruses. There's no evidence the viruses are dangerous, but they are scientifically interesting.
The New England Journal of Medicine published an editorial against quarantining people who have worked with Ebola patients in Africa. Renee Montagne speaks with Dr. Lindsey Baden, one of the authors.
Surgeons in Australia say they have performed the first heart transplant using a "dead heart".
Ebola underlines the urgent need for a new way of responding to global epidemics, say Harvey Rubin and Nicholas Saidel
As researchers from Africa to China to America race to develop vaccines and treatments to fight Ebola, health experts are grappling with the economics of a disease that until this year had been off the drug industry's radar.